Masafumi Haraguchi

Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings

Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi et al. · Cancers · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacology +14

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma

Ryu Sasaki, Kazuyoshi Nagata, Masanori Fukushima et al. · Cancers · 2022 · 39 citations · Full text

Medicine, Oncology, Radiology +17

Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP‑1 cells

Yuri Miyazoe, Satoshi Miuma, Hisamitsu Miyaaki et al. · Biomedical Reports · 2020 · 21 citations · Full text

Medicine, Cell Biology, Oncology +17

High serum concentrations of growth differentiation factor-15 and their association with Crohn’s disease and a low skeletal muscle index

Hiroyuki Yamamoto, Fuminao Takeshima, Masafumi Haraguchi et al. · Scientific Reports · 2022 · 20 citations · Full text

Medicine, Nutrition, Clinical Nutrition +16

Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis

Masafumi Haraguchi, Hisamitsu Miyaaki, Tatsuki Ichikawa et al. · Hepatology International · 2016 · 18 citations

Medicine, Internal Medicine, Physiology +14